SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Momenta Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


To: mcbio who wrote (2768)2/13/2011 1:01:04 PM
From: tom pope2 Recommendations  Respond to of 3027
 
MNTA is given to jokes, like trading below the price it was at before the mEnox approval.



To: mcbio who wrote (2768)2/13/2011 10:09:21 PM
From: rkrw  Read Replies (1) | Respond to of 3027
 
The bigger joke is listing Teva as a suitor. Conflicts on both of MNTA's primary assets.

As far as $21, throw in some contingent value rights and it might be considered a strong offer.